Clinical Supply, Gene and Gene Editing - Clinical Research Informer

Logistics in Focus: Orchestrating the Challenges of Cell Therapy

Worldwide Clinical Trials

NOVEMBER 12, 2024

By Amy Raymond, PhD, PMP, Executive Director, Therapeutic Strategy Lead, Rare Disease Cell and gene therapies (CGTs) include cutting-edge approaches that offer the hope of a healthier, happier, and better tomorrow for a wide range of patient populations. The global nature of cell and gene therapy trials adds another layer of complexity.

Gene Therapy

Gene Therapy Clinical Supply Trials Gene

Oxford Biomedica and Beam Therapeutics sign CAR-T deal

The Pharma Data

AUGUST 4, 2020

The agreement also puts in place a three year clinical supply agreement for the two companies. Under the terms of the deal, Oxford Biomedica will receive an undisclosed upfront payment, with additional payment related to development and manufacturing of lentiviral vectors for use in clinical trials. .

Gene Editing

Gene Editing Licensing Licensing Clinical Supply

Clinical Research Informer

Logistics in Focus: Orchestrating the Challenges of Cell Therapy

Oxford Biomedica and Beam Therapeutics sign CAR-T deal

Webinars

Stay Connected